A phase II study of lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck

Emer O. Hanrahan, Merrill S. Kies, Bonnie S. Glisson, Fadlo R. Khuri, Lei Feng, Hai T. Tran, Lawrence E. Ginsberg, Mylene T. Truong, Waun K. Hong, Edward S. Kim

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences